These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15258549)

  • 21. Nuchal translucency screening for chromosomal abnormalities in a routine ultrasound practice.
    Frohlich EP
    Prenat Diagn; 1997 Aug; 17(8):785-8. PubMed ID: 9267907
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening for nuchal translucency. Screening provides reliable information on which care can be based.
    Eustace DL
    BMJ; 1998 Sep; 317(7160):748. PubMed ID: 9841000
    [No Abstract]   [Full Text] [Related]  

  • 23. Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening.
    Prefumo F; Thilaganathan B
    Prenat Diagn; 2002 Oct; 22(10):917-8. PubMed ID: 12378577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.
    Adekunle O; Gopee A; el-Sayed M; Thilaganathan B
    Br J Radiol; 1999 May; 72(857):457-60. PubMed ID: 10505009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CGH analysis in a cohort of 17 chromosomally normal fetuses with an increased nuchal translucency.
    Brisset S; Romana S; Texier I; Lapierre JM; North MO; Vekemans M; Morichon-Delvallez N
    Prenat Diagn; 2003 Dec; 23(12):1017-8. PubMed ID: 14663841
    [No Abstract]   [Full Text] [Related]  

  • 27. Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss.
    Goetzl L; Krantz D; Simpson JL; Silver RK; Zachary JM; Pergament E; Platt LD; Mahoney MJ; Wapner RJ
    Obstet Gynecol; 2004 Jul; 104(1):30-6. PubMed ID: 15228997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal diagnosis of a supernumerary aberrant chromosome 9.
    Hengstschläger M; Bettelheim D; Dörfler-Grassauer D; Prusa AR; Drahonsky R; Deutinger J; Bernaschek G
    Arch Gynecol Obstet; 2003 Aug; 268(3):248-50. PubMed ID: 12942262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
    Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
    BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACOG committee opinion. First-trimester screening for fetal anomalies with nuchal translucency. Number 223, October 1999. Committee on Genetics. American College of Obstetricians and Gynecologists.
    Int J Gynaecol Obstet; 2000 Jan; 68(1):71-2. PubMed ID: 10687844
    [No Abstract]   [Full Text] [Related]  

  • 32. [Nuchal translucency: technical measurement and value].
    Broussin B; Sarramon MF
    J Radiol; 2002 Dec; 83(12 Pt 2):1891-8. PubMed ID: 12592151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enlarged nuchal translucency and low serum protein concentrations as possible markers for Zellweger syndrome.
    de Graaf IM; Pajkrt E; Keessen M; Leschot NJ; Bilardo CM
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):268-70. PubMed ID: 10341407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuchal translucency in the first trimester of pregnancy: ten years on and still a pain in the neck?
    Ville Y
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):5-8. PubMed ID: 11489217
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks].
    Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
    Akush Ginekol (Sofiia); 2004; 43(3):3-10. PubMed ID: 15341249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased nuchal translucency in fetuses with a normal karyotype.
    Hyett JA
    Prenat Diagn; 2002 Oct; 22(10):864-8. PubMed ID: 12378566
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
    Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G
    Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-trimester nuchal translucency screening for fetal aneuploidy.
    Sherer DM; Manning FA
    Am J Perinatol; 1999; 16(3):103-20. PubMed ID: 10438192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses.
    Michailidis GD; Economides DL
    Ultrasound Obstet Gynecol; 2001 Feb; 17(2):102-5. PubMed ID: 11251915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.